Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vesicular Monoamine Transporter II Imaging in Parkinson's Disease
NCT01556100Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2011
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by Chang Gung Memorial Hospital. Started Nov 2011; status: completed.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01556100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556100.